Roberta S. May, MA
- 2Articles
- 7.2KReads1
- 2005–2008Active
- 9Collaborators
About
Roberta S. May, MA, has published research on the augmentation of antipsychotic medications such as risperidone and haloperidol to serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder and suicidality in major depressive disorder. Her work, appearing between 2005 and 2008 in Psychiatrist.com journals, focuses on pharmacological strategies for managing obsessive-compulsive and related disorders as well as suicide risk. She has frequently collaborated with co-authors including Xiaohua Li, Daniel C. Dahl, and Hollis Reeves.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
